Share on StockTwits

NewLink Genetics Corp (NASDAQ:NLNK)’s share price traded up 6.7% during trading on Tuesday following a stronger than expected earnings report, American Banking reports. The company traded as high as $22.37 and last traded at $22.37, with a volume of 133,141 shares trading hands. The stock had previously closed at $20.97.

The company reported ($0.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.42) by $0.09.

Separately, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of NewLink Genetics Corp in a research note on Wednesday, May 7th. They now have a $51.00 price target on the stock, down previously from $53.00. Two research analysts have rated the stock with a buy rating, NewLink Genetics Corp currently has a consensus rating of “Buy” and an average target price of $39.00.

The stock has a 50-day moving average of $23.78 and a 200-day moving average of $27.53. The company’s market cap is $617.6 million.

NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.